The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to establish a new network entitled the Cancer Screening Research Network (CSRN) to conduct trials and studies specifically related to cancer screening. To support this initiative, the NCI intends to publish three Funding Opportunity Announcements (FOA) soliciting applications for UG1 cooperative research agreements to include Accrual, Enrollment, and Screening Site (ACCESS) Hubs, a Statistics and Data Management Center (SDMC), and a Coordinating and Communication Center (CCC). These entities will work collaboratively on CSRN trials and studies. The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will engage populations in rigorous studies focused on cancer screening to improve early cancer detection and evaluate emerging cancer-screening modalities and strategies, with the ultimate goal of reducing cancer incidence, and cancer-related morbidity and mortality. Within the new screening network, the SDMC will provide statistical leadership to ensure effective design, conduct, and analysis of CSRN trials and studies. In addition, it will provide centralized data management expertise, quality control, and reporting in support of cancer screening studies. The purpose of this Notice is to allow potential applicants sufficient time to develop meaningful collaborations among multi-disciplinary investigators with expertise in cancer screening and provide ample opportunity for organizations to develop responsive applications. The FOA is expected to be published in fall 2022 with an expected application due date in spring 2023. This FOA will utilize the UG1 activity code. Details of the planned FOA are provided below.
Brief Description